Tag: Valneva
Unusual volumes on the stock market today: Valneva
During this trading session on Tuesday June 20, 2023, particularly high trading volumes were detected on the French market. Today, it is the Valneva share that stands out, with trading…
Valneva: up sharply after a positive analysis – 06/16/2023 at 17:28
(CercleFinance.com) – Valneva shares ended the day up nearly 3%, benefiting from the positive analysis by Oddo BHF. In a note on European biotechnology stocks, Oddo BHF indicates that it…
Valneva: up sharply after a positive analysis
(CercleFinance.com) – Valneva shares ended the day up nearly 3%, benefiting from the positive analysis by Oddo BHF. In a note on European biotechnology stocks, Oddo BHF indicates that it…
Valneva: among Oddo BHF’s favorite European biotechs
(CercleFinance.com) – In a note on European biotechnology stocks, Oddo BHF indicates that it favors Valneva, as well as Abivax and Genfit, with ‘outperformance’ opinions and price targets raised to…
Valneva: positive results of the anti-chikungunya vaccine published in “The Lancet” – 06/13/2023 at 10:10
(AOF) – Valneva today announced that clinical data from the pivotal Phase 3 trial for its single-shot chikungunya vaccine candidate, VLA1553, has been published in “The Lancet”, “one of the…
Valneva: After the United States, Valneva applies to sell its anti-chikungunya vaccine in Canada
(BFM Bourse) – Valneva announces that it has submitted a marketing authorization request to Health Canada for VLA1553, its vaccine candidate against chikungunya, a viral disease transmitted by certain mosquitoes.…
Valneva: file filed in chikungunya in Canada – 05/30/2023 at 07:15
(CercleFinance.com) – Valneva announces that it has filed a marketing authorization (MA) application with Health Canada for its single-shot chikungunya vaccine candidate, VLA1553, for people aged 18 and over. more.…
Valneva: file filed in chikungunya in Canada
(CercleFinance.com) – Valneva announces that it has filed a marketing authorization (MA) application with Health Canada for its single-shot chikungunya vaccine candidate, VLA1553, for people aged 18 and over. more.…
Valneva: a presentation in Washington next week
(CercleFinance.com) – Valneva announced on Thursday that its chikungunya vaccine project would be presented at the World Vaccine Congress to be held next week in Washington. On Wednesday April 5,…
Valneva: losses widened in 2022 – 03/23/2023 at 08:00
(CercleFinance.com) – Valneva announces that it suffered a net loss of 143.3 million euros in 2022, compared to a loss of 73.4 million the previous year, as well as a…
Valneva: sharp increase in losses in 2022 – 03/23/2023 at 08:23
(AOF) – Valneva widened its losses in 2022. Its net loss stood at 143.3 million euros against -73.4 million euros in 2021. The vaccine specialist recorded an operating loss of…
Valneva: New data in Covid-19
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…